MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus

NCT00237653 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

40

Enrollment

OTHER

Sponsor class

Stopped difficulty to include patients

Conditions

Cytomegalovirus Infections
Inflammatory Bowel Diseases

Interventions

DRUG: Valganciclovir

Sponsor

University Hospital, Grenoble